FITC Mouse Anti-Human CD16 Antibody (S-R440)

產(chǎn)品型號(hào)：S0B5501

更新時(shí)間：2025-06-30

廠商性質(zhì)：生產(chǎn)廠家

訪問量：46

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

從實(shí)驗(yàn)室到臨床：蛋白激酶藥物的輝煌20年

視黃醇結(jié)合蛋白4（RBP4）抗體：發(fā)掘其在疾病風(fēng)險(xiǎn)中的診斷潛力

揭秘IL-31：為何它成為犬特應(yīng)性皮炎研究的熱點(diǎn)？

葉酸受體α在癌癥治療策略中的多面性

產(chǎn)品介紹

CD16, also known as FcγRIII, is a type of glycoprotein belonging to the immunoglobulin superfamily. It is divided into two subtypes: CD16a （FcγRIIIa） and CD16b （FcγRIIIb）. CD16a is a transmembrane protein mainly expressed on natural killer （NK） cells, monocytes, and some T cell subsets, while CD16b is a GPI-anchored protein primarily found on neutrophils. CD16a can mediate antibody-dependent cell cytotoxicity （ADCC） by binding to the Fc region of IgG antibodies, which is crucial for the immune system to eliminate virus-infected cells and cancer cells. Additionally, CD16a is one of the core markers for defining NK cells and can promote their proliferation and secretion of cytotoxic cytokines. In cancer immunotherapy, CD16a is an important target protein, and some monoclonal antibody drugs are designed to enhance its binding ability to boost immune responses.

上一個(gè)：S0B5503FITC Mouse Anti-Human CD27 Antibody (S-568-2)